| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| 20/20 Biolabs, Inc. | Chief Executive Officer, Director, 10%+ Owner | Common Stock | 1,366,400 | 17 Feb 2026 | Direct | ||
| 20/20 Biolabs, Inc. | Chief Executive Officer, Director, 10%+ Owner | Stock Option | 352,936 | 03 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000121390026023758-cohen-jonathan-m-2026-03-03 | 20/20 Biolabs, Inc. | 03 Mar 2026 | 1 | $0 | 4 | Chief Executive Officer, Director, 10%+ Owner | 04 Mar 2026, 17:48 |
| /report/000121390026018516-cohen-jonathan-m-2026-02-17 | 20/20 Biolabs, Inc. | 17 Feb 2026 | 0 | $0 | 3 | Chief Executive Officer, Director, 10%+ Owner | 19 Feb 2026, 17:52 |